# ZHENGYE BIOTECHNOLOGY HLDG L ORD SHS

ZHENGYE BIOTECHNOLOGY HLDG L ORD SHS is a security (CUSIP G989MS101) tracked across SEC portfolio filings. 9 institutional managers reported $113K on Form 13F as of 2026-06-30.

## Summary

- Issuer: ZHENGYE BIOTECHNOLOGY HLDG L
- Class: ORD SHS
- CUSIP: G989MS101
- 13F holders: 9
- 13F value: $113K
- 13F period: 2026-06-30
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| XTX Topco Ltd | LONDON, X0 | $41K | 44,146 |
| WINTON GROUP Ltd | LONDON, X0 | $31K | 33,389 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://search.stillhousedata.com/firm/115504) | BOSTON, MA | $27K | 29,068 |
| UBS Group AG | Zurich, V8 | $8K | 8,036 |
| Tower Research Capital LLC (TRC) | NEW YORK, NY | $5K | 4,912 |
| Royal Bank of Canada | TORONTO, A6 | $1K | 1,230 |
| MORGAN STANLEY | NEW YORK, NY | $244 | 261 |
| Caitong International Asset Management Co., Ltd | HONG KONG, K3 | $1 | 1 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/G989MS101.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.